Statement from FDA Commissioner Scott Gottlieb, MD, on the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse – FDA.gov

Statement from FDA Commissioner Scott Gottlieb, MD, on the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse  FDA.gov

Over the past several months, there have been many questions raised about the botanical substance known as kratom. Our concerns related to this product, and …